Wilson Marc has filed 32 insider transactions across 1 company since May 2022.
Most recent transaction: a transaction of 473 shares of Crinetics Pharmaceuticals, Inc. ($CRNX) on November 20, 2024.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | J | Common Stock | 473 | $14.98 | 111,565.0000 | 68,175,000 | 0.43% | 0.00% |
| Sept. 26, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 25000 | $15.29 | 136,092.0000 | 68,175,000 | 22.50% | 0.04% |
| Sept. 26, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 25000 | $51.11 | 111,092.0000 | 68,175,000 | 18.37% | 0.04% |
| Sept. 26, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Stock option (Right to Buy) | 25000 | $0.00 | 89,000.0000 | 68,175,000 | 21.93% | 0.04% |
| July 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 19056 | $9.28 | 130,148.0000 | 68,175,000 | 17.15% | 0.03% |
| July 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 19056 | $53.88 | 111,092.0000 | 68,175,000 | 14.64% | 0.03% |
| July 25, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Stock option (Right to Buy) | 19056 | $0.00 | 0.0000 | 68,175,000 | 100.00% | 0.03% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 25000 | $20.02 | 136,092.0000 | 68,175,000 | 22.50% | 0.04% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 25000 | $55.00 | 111,092.0000 | 68,175,000 | 18.37% | 0.04% |
| July 15, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Stock option (Right to Buy) | 25000 | $0.00 | 66,000.0000 | 68,175,000 | 27.47% | 0.04% |
| June 28, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 32129 | $9.28 | 143,221.0000 | 68,175,000 | 28.92% | 0.05% |
| June 28, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 32129 | $43.61 | 111,092.0000 | 68,175,000 | 22.43% | 0.05% |
| June 28, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Stock option (Right to Buy) | 32129 | $0.00 | 19,056.0000 | 68,175,000 | 62.77% | 0.05% |
| March 18, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | F | Common Stock | 3983 | $38.14 | 117,572.0000 | 68,175,000 | 3.28% | 0.01% |
| March 19, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 6942 | $42.91 | 110,630.0000 | 68,175,000 | 5.90% | 0.01% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | A | Common Stock | 25500 | $0.00 | 121,555.0000 | 68,175,000 | 26.55% | 0.04% |
| March 4, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | A | Stock Option (right to buy) | 95500 | $0.00 | 95,500.0000 | 68,175,000 | 9999.99% | 0.14% |
| Jan. 2, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 10000 | $9.28 | 106,055.0000 | 68,175,000 | 10.41% | 0.01% |
| Jan. 2, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 10000 | $35.47 | 96,055.0000 | 68,175,000 | 9.43% | 0.01% |
| Jan. 2, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 10000 | $0.00 | 51,185.0000 | 68,175,000 | 16.34% | 0.01% |
| Nov. 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 10000 | $9.28 | 105,601.0000 | 32,344,371,000 | 10.46% | 0.00% |
| Nov. 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 10000 | $28.75 | 95,601.0000 | 32,344,371,000 | 9.47% | 0.00% |
| Nov. 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 10000 | $0.00 | 61,185.0000 | 32,344,371,000 | 14.05% | 0.00% |
| June 20, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 10922 | $19.96 | 95,158.0000 | 0 | 10.30% | 0.00% |
| June 20, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Common Stock | 20000 | $9.28 | 115,158.0000 | 0 | 21.02% | 0.00% |
| June 20, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | S | Common Stock | 20000 | $19.97 | 95,158.0000 | 0 | 17.37% | 0.00% |
| June 20, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 20000 | $0.00 | 71,185.0000 | 0 | 21.93% | 0.00% |
| March 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | F | Common Stock | 1666 | $17.12 | 106,080.0000 | 0 | 1.55% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | A | Common Stock | 24200 | $0.00 | 107,746.0000 | 0 | 28.97% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | A | Stock Option (right to buy) | 112850 | $0.00 | 112,850.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2022 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | J | Common Stock | 1446 | $11.02 | 83,064.0000 | 0 | 1.77% | 0.00% |
| Nov. 20, 2022 | Crinetics Pharmaceuticals, Inc. | $CRNX | Wilson Marc | CFO | J | Common Stock | 482 | $11.02 | 83,546.0000 | 0 | 0.58% | 0.00% |